Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Marqueurs Pronostiques et prédictifs de réponse Aux Traitements Chez Les Patients Atteints de Cancer Des Voies Biliaires : Cohorte Multicentrique ACABi PRONOBIL

NCT04935853 is registered in ClinicalTrials.gov with GERCOR - Multidisciplinary Oncology Cooperative Group as lead sponsor.

NCT NCT04935853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04935853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Marqueurs Pronostiques et prédictifs de réponse Aux Traitements Chez Les Patients Atteints de Cancer Des Voies Biliaires : Cohorte Multicentrique ACABi PRONOBIL
Lead sponsor
GERCOR - Multidisciplinary Oncology Cooperative Group
Phase
Observational
Overall status
Recruiting
Start date
May 23, 2022
Completion date
June 1, 2040
Enrollment
1,350 (estimated)
Sites
32

Conditions

As the registry lists them; a condition with its own page is linked.

biliary tract cancer